Celsis International is offering its rapid microbial detection capability as an outsourced service for pharmaceutical and consumer products companies. According to the company, the results — presence or absence of microbial contamination — are delivered in less than half the time as conventional agar methods, according to the company. Earlier identification of contamination allows for faster corrective action. The company’s proprietary ATP bioluminescence technology offers spee...